Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNOS
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
23650 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*10= 22500.00 + 45*50*1=1150.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION)
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNOS
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
23700 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE+EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION,1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED=45*50*10= 22500.00+45*50*1=1200.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BN LI
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
22500 PCS LIGNOSAPH-PLUS LIDOCAIN HYDROCHLORIDE+EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED=45*50*10=22500.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BNLIGNOSAPH-PLUS
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH-PLUS LIDOCAIN HYDROCHLORIDE+EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED=45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BN LIGNOSAPH-PLUS
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
23700 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*10= 22500.00 + 45*50*1=1200.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION)
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNOS
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
Trade date
2026/04/15
B/L No.
008879
Suppliers
althea pharma pvt ltd.
Buyers
nelpa lifesciences inc.
Product description
24750 PCS LIGNOSAPH -PLUS LIDOCAIN HYDROCHLORIDE +EPINEPHRINE 20 MG /10 MCG PER ML SOLUTION FOR INJECTION, 1.8ML GLASS CARTRIDGES TOTAL EXEMPTED MATRIALS CONSUMED = 45*50*11= 24750.00 CARTRIDGES (20MG/10MCG PER ML SOLUTION FOR INJECTION) BRAND NAME LIGNO
Expand
althea pharma pvt ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bt,bat,harmless medicines.
According to the 52wmb.com global trade database, as of 2026-06-29, the company has completed 4581 international trades,
with its main trading regions covering uganda,philippines,yemen etc.
The core products include HS30049099,HS30049099000,HS90183990 etc,
often transported via jnpt,port nhava sheva sea innsa1, port jawaharlal nehru (nhava sheva) etc,
and its main trading partners are joint medical stores,ie ak maya,nelpa lifesciences inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on althea pharma pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.